oxycodone immediate-release

DRUG2 trials

Sponsors

Purdue Pharma LP

Conditions

Back Pain Lower Back ChronicOsteoarthritis

Phase 3

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain

TerminatedNCT00312221

Purdue Pharma LPOsteoarthritis

Start: 2004-04-30End: 2005-08-31Updated: 2012-09-10

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain

TerminatedNCT00313014

Purdue Pharma LPBack Pain Lower Back Chronic

Start: 2004-02-29End: 2005-09-30Updated: 2012-09-03

Related Papers

Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.

2017-05-248 citations